naringenin has been researched along with Carcinoma, Anaplastic in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ekambaram, G; Magesh, V; Rajendran, P; Sakthisekaran, D | 1 |
Cho, SG; Choi, HY; Han, YS; Kang, GH; Kang, YJ; Kim, BW; Kim, JH; Lee, ER; Nah, SY; Paik, HD; Park, YS | 1 |
2 other study(ies) available for naringenin and Carcinoma, Anaplastic
Article | Year |
---|---|
Naringenin reduces tumor size and weight lost in N-methyl-N'-nitro-N-nitrosoguanidine-induced gastric carcinogenesis in rats.
Topics: Animals; Antineoplastic Agents; Antioxidants; Carcinoma; Cysteine; Disease Models, Animal; Flavanones; Gastric Mucosa; Lipid Peroxidation; Male; Methylnitronitrosoguanidine; Oxidation-Reduction; Random Allocation; Rats; Rats, Wistar; Reactive Oxygen Species; Stomach Neoplasms; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances; Weight Loss | 2008 |
Induction of apoptotic cell death by synthetic naringenin derivatives in human lung epithelial carcinoma A549 cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Carcinoma; Caspase 3; Cell Line, Tumor; Cell Survival; Flavanones; Fluorescent Dyes; Humans; Hydroxylation; Indoles; Lung Neoplasms; Reactive Oxygen Species | 2007 |